Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignanciesREZAEI, Nima; HEDAYAT, Mona; AGHAMOHAMMADI, Asghar et al.Journal of allergy and clinical immunology. 2011, Vol 127, Num 6, pp 1329-1341, issn 0091-6749, 13 p.Article

X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitisKANEGANE, Hirokazu; ITO, Yoshikiyo; OHSHIMA, Koichi et al.American journal of hematology. 2005, Vol 78, Num 2, pp 130-133, issn 0361-8609, 4 p.Article

X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphomaREZAEI, Nima; MAHMOUDI, Elham; AGHAMOHAMMADI, Asghar et al.British journal of haematology. 2011, Vol 152, Num 1, pp 13-30, issn 0007-1048, 18 p.Article

Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysisKANEGANE, Hirokazu; XI YANG; TERUI, Kiminori et al.Pediatric allergy and immunology. 2012, Vol 23, Num 5, pp 488-493, issn 0905-6157, 6 p.Article

Sequence Analysis of BIRC4/XIAP in Male Patients with Common Variable ImmunodeficiencySALZER, Ulrich; HAGENA, Tina; WEBSTER, David B et al.International archives of allergy and immunology. 2008, Vol 147, Num 2, pp 147-151, issn 1018-2438, 5 p.Article

Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndromeSTRNAD-TROJAN, Nicola; LINDE, Richard; REICHENBACH, Janine et al.European journal of pediatrics. 2006, Vol 165, Num 5, pp 348-350, issn 0340-6199, 3 p.Article